Suppliers

Almac Group

Almac

Integrated Solutions from Research to Commercialisation.

 

Almac​ is a financially secure, privately owned organisation with over 3,300 employees located within the US and UK. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30+ years.

 

Our vast range of services include:

 

Biomarker Discovery & Development​: Pre-clinical biomarker discovery, through to full companion diagnostic development and clinical test delivery from our CLIA laboratory.

 

API Services & Chemical Development: ​Services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides.
 

 

Pharmaceutical Development: ​Developing clinical candidates into an optimum formulation and manufacturing drug product for all phases of clinical trial supply.

 

Analytical Services: ​Delivering comprehensive solutions supporting drug substance and product development programmes.

 

Clinical Trial Supply: ​Offering over 20 years experience in clinical supply, packaging, distribution and management.

 

Clinical Technologies: ​Providing interactive voice and web response technologies, flexible solutions for patient enrollment, electronic ePROs and adaptive trials.

 

Commercial Services: ​Services for all drug products from manufacturing, testing and packaging to end-user distribution.

Almac – Partnering to Advance Human Health™

Related resources

show more

Temperature-Controlled IMP Distribution Challenges

Temperature-Controlled IMP Distribution Challenges

Almac Group | 04-Aug-2014 | Technical / White Paper

UNDERSTANDING THE CHALLENGES OF TEMPERATURE CONTROLLED INVESTIGATIONAL MEDICINAL PRODUCT DISTRIBUTION IN EMERGING MARKETSTemperature deviation within the...

Forecasting strategies to optimize clinical trials

Forecasting strategies to optimize clinical trials

Almac Group | 03-Mar-2014 | Technical / White Paper

In a market that is constantly evolving, where rising complexities and costs associated with product development and clinical trial conduct present new...